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ObjectiveaaPsychotherapeutic intervention combined with pharmacotherapy is helpful for 
achieving remission of depressive disorder. We developed and tested the effect of cognitive 
behavior therapy (CBT)-based psychotherapy applied in a forest environment on major de-
pressive disorder. 
MethodsaaWe performed 4 sessions during 4 weeks (3 hours/session) in patients with major 
depressive disorder during pharmacotherapy. For the forest group, sessions were performed 
in the forest; for the hospital group, sessions were performed in the hospital. The control 
group was treated with the usual outpatient management. 
ResultsaaA total of 63 patients completed the study: 23 in the forest group, 19 in the hos-
pital group, and 21 in the control group. Hamilton Rating Scales for Depression (HRSD) 
scores of the forest group were significantly decreased after 4 sessions compared with con-
trols. Montgomery-Asberg Depression Rating Scales (MADRS) scores of the forest group 
were significantly decreased compared with both the hospital group and the controls. The 
remission rate (7 and below in HRSD) of the forest group was 61% (14/23), significantly 
higher than both the hospital group (21%, 4/19) and the controls (5%, 1/21). In heart rate 
variability (HRV) analysis, some measurements representing HRV and parasympathetic 
nerve tone were increased in the forest group after 4 sessions. The salivary cortisol levels 
of the forest group were significantly decreased. 
ConclusionaaCBT-based psychotherapy applied in the forest environment was helpful in 
the achievement of depression remission, and its effect was superior to that of psychother-
apy performed in the hospital and the usual outpatient management. A good environment 
such as a forest helps improve the effect of psychotherapeutic intervention because it in-
cludes various natural instruments and facilitators in the treatment of depression.   
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Introduction 
 
Major depressive disorder is a long-lasting illness with significant effects on family, 
social, and work life.
1,2 Because of its high prevalence, its resultant socioeconomic 
burden is growing, and has become even higher than angina, arthritis, asthma, or di-
abetes.
3 Treatment failure results in frequent relapses and a low recovery rate.
4 Up 
until 10-20 years ago, the treatment goal of depression was merely relief of acute
symptoms by pharmacotherapy or psychotherapy.
5,6 Recently it was shown that pa-
tients continuously suffer from residual depressive symptoms and have high relapse 
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rate and poor prognosis when in partial remission.
8 With 
the advent of fluoxetine, antidepressants started show-
ing fewer side effects and improved patient medication 
compliance.
9 Therefore, a consensus arose to adjust ther-
apeutic goals to complete remission rather than merely 
symptomatic improvements.
10 Correspondingly, after year 
2000, practice guidelines of major countries including 
the United States and England encouraged changing the 
therapeutic goal of major depressive disorder to induce 
complete remission,
11 and recently the therapeutic guide-
line from the Korean Society of Depressive and Bipolar 
Disorder recommended ‘recovery of all pre-morbid func-
tions through a complete remission’ as a new therapeutic 
goal.
12 
Much effort is required to achieve complete remission. 
A combination of substantial amounts of maintenance 
therapy, antidepressant medications, and education is used 
to increase patient adaptation. The antidepressant-only 
remission rate is usually not higher than 40% in well-
designed double blind studies.
13 It was thought that com-
bination pharmacotherapy and psychotherapy would help 
increase remission rates
14 because it is difficult for pa-
tients to immediately recover vitality simply by norma-
lizing neurotransmitter metabolisms inside the brain after 
a long-lasting lethargic condition and habitual low acti-
vity levels. The physical symptoms of anxiety disorder are 
readily responsive to medications, but behavioral symp-
toms such as avoidance responds better to cognitive be-
havior therapy (CBT).
15 Use of CBT in depressive pa-
tients has proven effective and is being widely applied, 
and behavioral techniques that are used to increase pa-
tient activity can also be used for rehabilitation and re-
lapse prevention.
16 Therefore, a combination of adequate 
pharmacotherapy and psychotherapy is helpful to achieve 
complete remission of major depressive disorder. 
Commonly used psychotherapies for depression include 
CBT and interpersonal therapy. CBT has been globally 
applied since Aaron Beck
17 introduced its effectiveness 
on treating depression, and numerous manuals are av-
ailable for formulating different goals like reduction of 
acute symptoms or prevention of relapse. Mindfulness-
based cognitive therapy (MBCT) was recently proven 
effective to prevent relapse of depression, and other mo-
dified therapies are continuously advancing.
18,19 Moreover, 
positive psychological interventions are being tested for 
the treatment of depression.
20,21 
Traditional psychotherapy was performed through con-
versation between doctor and patient in the office, but 
modern psychotherapies also use various activities, me-
ditation, and behavioral experiments. We suggest that a 
natural environment may be more effective than a gray 
office. Natural environments are known to positively in-
fluence human health by common sense. Environmental 
psychologists insist that the physical and psychological 
problems of modern society are associated with discon-
nection between human beings and their natural envi-
ronment.
22 Nilson
23 asserted that forests provide oppor-
tunities to eliminate elements that are harmful to human 
health. A study from Japan showed that simply staying 
in, looking around, or strolling through a forest can ac-
tivate the frontal cortex, lower blood pressure and blood 
cortisol levels, promote body relaxation, and strengthen 
immunity by activating natural killer cells.
24 
In addition to the physiological effects, environmental 
psychology hypotheses proposed that forests can positi-
vely influence human minds and activities. One of those 
is the attention recovery theory that states that human can 
experience recovery from fatigue in natural environ-
ments.
25 According to this theory, humans are exhausted 
from various artificial stimulations, but nature provides 
a restorative environment that reduces tiredness, increases 
cognitive ability, and provides psychological recovery.
26 
Another hypothesis is that humans tend to observe or in-
teract with animals or plants in nature, which brings tr-
eatment effects.
27 Some opinions even state that nature 
induces coping responses rather than the defensive reac-
tions that come from interpersonal relationships or art-
ificial structures. According to Pryor et al.
28 participants 
who attended a forest program showed increased con-
fidence, subjectively better well-being, and higher self-
esteem. The forest program also increased self-confid-
ence, improved self-esteem,
29 increased socialization and 
school attitudes,
30 and effectively promoted both quan-
tity and quality in social relationships.
31 
We proposed to test the effects of a forest environment 
as a psychotherapeutic element. Various advantages would 
presumably exist, including: increased movements for ch-
ronically lethargic patients; a natural and easy setting for 
completion of meditation techniques; and facilitated con-
versation with nature or colleagues. Because of these ad-
vantages, better therapeutic effects may be expected. This 
study aimed to reveal the effects of CBT intervention on 
major depressive disorder in a forest setting compared 
with the same intervention performed in a hospital or by 
usual outpatient management. Physiological parameters 
such as heart rate variability (HRV) and salivary cortisol 
concentrations were assessed in addition to changes of 
depressive symptoms. 
 
Methods 
 
Participants of the study 
Seventy-three patients diagnosed with major depres-
sive disorder at one university hospital located in Seoul  
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participated in this study. Diagnosis was made by at least 
two psychiatrists based on DSM-IV-TR and was confirm-
ed by Structured Clinical Interview for DSM disorders 
(SCID)32 in Korean language. Participants were selected 
among patients showing more than moderate severity 
according to the Hamilton Rating Scales for Depression 
(HRSD) score of above 25 before treatment with medi-
cation. All subjects were under pharmacotherapy treat-
ment for 3 months and were relieved from acute severe 
symptoms but had not achieved remission and had not 
shown improved HRSD scores during the 2 weeks be-
fore the study began. 
During the 4-week study program, all medications 
were maintained according to each patient’s previous 
treatment schedule. Subjects who had any medico-sur-
gical illnesses or any Axis I disorders other than major 
depressive disorder were excluded from this study. 
All participants were fully informed about the study 
program and signed the participant agreement form. Af-
ter joining this trial, each participant was assigned to the 
forest group, hospital group or outpatient control group 
according to sign-up sequence. Those who were assigned 
to the hospital or control groups were given the oppor-
tunity to participate in the forest program after the trial. 
Initially, participants were assigned to the groups as 
follows: 25 in the forest group, 24 in the hospital group, 
and 24 patients in the outpatient control group. There was 
no difference in HRSD score or Montgomery-Asberg 
Depression Rating Scale (MADRS)(F=0.358, p=0.701; 
F=0.499, p=0.609) before starting the study. This pro-
gram was approved by the Institutional Review Board 
of Seoul Paik hospital (IJSP-2007-IIT-127). 
 
Measurement of depressive symptoms 
HRSD was developed by Hamilton
33 for measurement 
of patients’ depressive symptoms by clinicians. Reduc-
tion of the score to half equals treatment response and a 
score below 7 is defined as remission by many experts. 
For our study, a Korean version of the HRSD standar-
dized by Yi et al.
34 was used.   
Montgomery and Asberg
35 developed MADRS to im-
prove the ability to evaluate treatment response. MADRS 
is a 10-item questionnaire dividing the severity into grades 
0 to 6. It contains more psychological items than HRSD, 
which includes many physical items that mask the treat-
ment response. In this study, a Korean version standar-
dized by Ahn et al.
36 was used.   
Beck Depression Inventory (BDI) is a 21-item self-
report inventory test designed by Beck
37 to measure the 
emotional, cognitive, and physiological aspects of depres-
sive symptoms. This study used the Korean version st-
andardized by Song.
38 
Short Form Health Survey Questionnaire 
SF-36 is a general health survey developed by Ware 
and Sherboune
39 and revised by Ko et al.
40 into Korean. 
It has 36 questions divided into 9 sections applicable to 
investigations about clinical studies, health policy evalu-
ation, and the working population. It deals with general 
aspects including physical and psychological status that 
influence health. Total score is a sum of subcategory 
scores consisting of functional status, well-being, and 
overall health evaluation. Among these, functional st-
atus is a sum of 4 sections (physical functioning, social 
role functioning, physical role functioning, and emotio-
nal role functioning). Well-being is the sum of 3 sections 
(mental health, vitality, bodily pain) and overall evaluat-
ion of health is the sum of 2 sections (general health per-
ceptions and change of health status). Sometimes, ex-
cluding the change of health status section, 8 sections are 
divided into 2 categories of physical health and mental 
health.
41 Physical health is the sum of physical function-
ing, physical role functioning, body pain, and general he-
alth perception, while mental health is the sum of vitality, 
social role functioning, emotional role functioning, and 
mental health. Every section uses Likert scale for scoring, 
which gives 1 point to unhealthy aspects and maximum 
points between 2 and 6.   
 
Measurement of biological index 
 
Heart Rate Variability 
HRV was measured with the emWave PC Stress Re-
lief System (HeartMath LLC, Boulder Creek, CA, USA). 
In a relaxed sitting position, participants waited until any 
interrupting waves disappeared. When repetitive clean 
waves consistently appeared, HRV was measured for 5 
minutes.  
The HRV analysis is based on the beat-to beat varia-
tion of heart beat within a certain range. Heart rate is con-
trolled by the autonomic nervous and endocrine systems. 
High HRV means a condition of variable heart rate wi-
thin a unit time. It is the flexibility of heart to adapt to 
different situations and can be used for a predictor of 
mortality after acute myocardial infarction.
42 The most 
commonly used parameters include the standard devia-
tion of ‘normal RR interval (NN interval)’ (SDNN) of the 
electrocardiogram and the root mean square successive 
difference (RMSSD). By Fourier transformation, basic 
wavelength functions could be converted to power ana-
lysis of frequency domain. Through this, total power (TP) 
of HRV according to the frequency domain-high frequ-
ency (HF), low frequency (LF), and very low frequency 
(VLF)-are acquired. It is known that HF power reflects 
parasympathetic activity and that the LF/HF ratio reflects  
 
 
 
 
CBT for Major Depression in a Forest 
248 Psychiatry Invest 2009;6:245-254 
sympathetic activity.
43 Although the limitations of indi-
vidual difference and variation between measurements 
exist, HRV is widely used because it can non-invasively 
measure responses of the autonomic nervous system. 
 
Salivary Cortisol Concentration 
A commercial kit was used to determine salivary cor-
tisol concentration by ER HS Salivary Cortisol (Salime-
trics, State College, PA, USA). Participants were asked 
to chew a cotton ball with their molars for at least 1 mi-
nute and the collected cotton specimens were stored in 
the refrigerator until use. Saliva was soaked out by cen-
trifugation at 2,500 r.p.m. for 2 minutes. After addition of 
25 μL test reagents into the saliva, 100 μL enzyme con-
jugate solution was added. After tapping the well-shaped 
groove for 5-10 seconds, light was eliminated and the 
enzymatic reaction was performed at room temperature 
with gentle shaking at 500-700 r.p.m. for 10-15 minutes. 
The absorbance at 450 nm was read with an E Max Pre-
cision microplate reader (Molecular Device, Sunnyvale, 
CA, USA). 
 
Schedule of assessment and treatment programs 
Participants of each program attended once a week 
according to the study design. The forest program pro-
ceeded at the Hong-Reung arboretum for 4 weeks with 
weekly 3-hour sessions, 10 a.m. to 1 p.m. on Wednesdays. 
The Hong-Reung arboretum is a forest garden with a 
total of 440 thousand square meters of acicular trees, 
broad-leaf trees, shrubs, herb gardens, and alpine plants. 
It has a display of 20 thousand plants classified into 157 
branches and 2,035 species and 4,245 collections of fos-
silized leaves and specimens. It is an experimental forest 
that was established for collecting and managing of plant 
resources and performance of forestry research. The hos-
pital program proceeded for 4 weeks with weekly 3-hour 
sessions every Thursday in the room of Seoul Paik Hos-
pital with the same format as the forest program. Sessions 
of each group were performed and evaluated by two mas-
ter’s-level psychologists following the same manual. The 
control group was treated with usual outpatient manage-
ment. HRSD, MADRS, and BDI were measured weekly, 
and SF-36 was evaluated only in the first and last week. 
HRV and salivary cortisol were measured at 10 a.m. on 
the first and last weeks’ sessions. 
 
Contents of the treatment programs 
CBT is a structured treatment method with various 
techniques made by the assumption that cognitive dis-
tortions causes negative thoughts in depression. Our pro-
gram was designed to use the forest environment as a 
mediator of CBT by facilitating patients to reflect their 
problems and try to reconstruct cognitive error after st-
rolling in the forest or hearing stories about trees. Beha-
vioral intervention was implemented to stimulate the vi-
tality of patients with decreased activity levels that need-
ed implementation of mediator-stimulated drive. Both the 
forest and the trees were actively used for this purpose. 
Mindfulness meditation is a form of insight medita-
tion, maintaining awareness of the moment. Respiratory 
mindfulness meditation, which is easily applicable to the 
general public, observes an individual’s breathing sensa-
tions without judgment and makes it possible to feel his 
mind as it is and induce physiological relaxation. Our 
program used this meditation technique by focusing on 
breath, wind in the forest, and sounds. 
The concepts of positive psychology were introduced 
to improve participants’ quality of life. Seligman et al.
21 
reported that methods to get positive emotions include 
‘talking about three things that were good today’, ‘gra-
titude to others’, and ‘using my strengths’, all of which 
bring happiness and decrease the depressive mood. Our 
programs used the ‘gratitude to others’ and ‘using my st-
rengths’ components. 
The hospital program was performed in the same way 
as the forest program but in an indoor setting. For ex-
ample, forest observation was substituted with watching 
window scenery or objects in the room, and use of forest 
objects was substituted with use of other objects or im-
agining something good during meditation. 
 
Statistical analysis 
The demographic data of participants (forest program 
group, hospital program group, outpatient control group) 
was compared by independent t-test. Repeated measures 
of analysis of variance (repeated ANOVA) were used to 
compare the symptomatic improvement of depressive 
symptoms before and after the program. Post hoc analy-
sis for group difference was verified by Bonferroni’s me-
thod. Group difference of remission induction was com-
pared by χ2 test. Paired t-test was used for HRV, salivary 
cortisol concentration and change of SF-36. 
 
Results 
 
General characteristics of participants 
Of the initial 73 participants, 23 in the forest group, 
19 in the hospital group, and 21 in the outpatient control 
group completed the whole program. Two patients drop-
ped out of the forest group: one developed a rash caused 
by an insect bite on forest and withdrew consent; the other 
missed one session due to personal circumstances. No pa-
tients dropped out of the other groups due to side effects. 
Demographic characteristics of participants are sum- 
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marized in Table 1. There was no group difference in de-
mographic characteristics or age of depression onset (Ta-
ble 1). 
 
Changes of depressive symptoms 
 
Hamilton Rating Scales for Depression 
Analyzed by repeated measures of ANOVA, HRSD 
score decreased in a time-dependant manner (F=43.16, 
p<0.01). Group differences existed (F=3.95, p<0.05), 
which suggests a difference of effectiveness between 
programs. 
The change in mean HRSD score before and after per-
forming the program was 15.54 to 8.04 in the forest pro-
gram; 15.79 to 11.58 in the hospital group; and only mi-
nimally decreased from 16.90 to 14.85 in the outpatient 
control group. By Bonferroni post-hoc test, a difference 
between forest and outpatient group existed (p<0.05) but 
was not seen in either the forest group vs. hospital group 
or the hospital group vs. outpatient control group (Figure 1). 
 
Montgomery-Asberg Depression Rating Scales 
By repeated measures of ANOVA, MADRS decreased 
in a time-dependant manner (p<0.01). A group difference 
was also seen (p<0.01). Mean MADRS scores changed 
from 23.70 to 11.83 in the forest group, 25.37 to 20.32 
in the hospital group, and only minimally from 25.24 to 
23.33 in the outpatient control group. Bonferroni post-hoc 
test showed meaningful differences between the forest 
group and both the outpatient control group (p<0.01) and 
the hospital group (p<0.05) were meaningful. The forest 
program more effectively improved MADRS scores than 
did the hospital or outpatient control programs (Figure 2). 
TABLE 1. The demographic characteristics of all participants
 Forest  group  (n=23) Hospital  group  (n=19) Controls  (n=21) p 
Age (years)  043.39±12.14  044.26±13.49  048.76±09.63 0.093 
Sex (male : female) 3  : 20  2 : 17  4 : 17  0.727 
Weight (kg)  054.90±08.32  059.94±13.87  061.72±10.20 0.141 
Height (cm) 161.15±04.72 160.13±11.37 161.50±09.21 0.892 
<9 year  05  04  06 
9-12 year  10  06  08 
Education 
>12 year  08  09  07 
0.860 
Married 14  10  15  Marrital status 
Single  09  09  06 
0.470 
Age of onset (years) 38.57±10.99  043.60±13.64  043.25±08.35 0.266 
Number of psychiatric admission  00.96±01.75  001.19±02.07  001.43±01.36 0.601 
Number of depressive episode  01.67±01.59  001.89±02.09  001.79±02.64 0.583 
Mean±SD, n 
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FIGURE 1. The change of HRSD scores in forest group, hospital
group, and controls during 4 week program. The repeated meas-
ure ANOVA showed a significant time effect (F=43.16, p<0.001)
and a significant between-group effect (F=3.95, p=0.025). *Post
hoc analysis showed only the difference between forest group and
controls, p=0.020. HRSD: Hamilton Rating Scales for Depression,
repeated ANOVA: repeated measure of analysis of variance.   
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FIGURE 2. The change of MADRS scores in forest group, hospi-
tal group, and controls during 4 week program. The repeated meas-
ure ANOVA showed a significant time effect (F=43.25, p<0.001)
and a significant between-group effect (F=5.69, p=0.005). *Post
hoc analysis showed not only the difference between forest group
and controls (p<0.007), **But also the difference between forest
group and hospital group (p<0.048). MADRS: Montgomery-As-
berg Depression Rating Scales. repeated ANOVA: repeated meas-
ure of analysis of variance. 
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Beck Depression Inventory 
Repeated measures of ANOVA showed a time-depen-
dent improvement of BDI score (p<0.01), but no group 
difference existed. 
 
Remission Induction Rate 
As previously described, no difference existed in HR-
SD score between the forest and hospital groups. Ins-
tead, we compared the ratio of remission induction de-
termined by an HRSD score less than 7. The number of 
patients reaching remission was 14 of 23 (61%) in the 
forest group, 4 of 19 (21%) in the hospital group, and 1 
of 21 (5%) in the outpatient control group. Significant 
differences existed between groups (p<0.01), and the 
Bonferroni post-hoc test showed that the forest group 
was more effective in inducing remission than hospital 
group (p<0.05)(Table 2). 
 
Biological index 
 
Heart Rate Variability 
Among the various HRV indices, the 4-week forest 
program increased SDNN, RMSSD, and TP, which are 
parameters of the total amount of HRV (p<0.01; p<0.05; 
p<0.01). HF, the index of parasympathetic tone, also in-
creased (p<0.05). In the hospital group, only normalized 
TABLE 2. The numbers of remitter after 4 week program in forest group, hospital group, and controls
  Forest group  Hospital group  Controls  χ2 p 
Numbers of remitter  14  04  01 
Numbers of non-remitter  09 15  20 
17.5 <0.001 
Total 23  19  21   
Post hoc analysis showed also the difference between forest group and hospital group (χ2=6.74, p=0.027) 
 
TABLE 3. Heart Rate Variability (HRV) measures before and after 4 week program in forest group, hospital group, and controls
  HRV parameters  Before the 4 week program After the 4 week program  t  p 
SDNN  00.026 (0.013)  00.038 (0.019) -3.18  0.004 
RMSSD  022.04 (17.44)  033.09 (22.26) -2.83  0.010 
Trianular index  00.047 (0.017)  00.055 (0.026) -1.24  0.238 
Total power  0406.3 (460.7)  0853.4 (667.8) -3.09  0.006 
LF power  0149.1 (241.4)  0249.2 (224.3) -1.69  0.104 
HF power  0178.4 (192.7)  0347.1 (322.1) -2.74  0.013 
LF/HF ratio  01.140 (0.746)  01.633 (1.359) -1.59  0.126 
Norm. LF power  036.48 (15.73)  045.35 (22.32) -1.37  0.186 
Forest group 
Norm. HF power  052.44 (17.24)  039.93 (18.93) 2.12  0.068 
SDNN  00.039 (0.023)  00.042 (0.038) -0.29  0.772 
RMSSD  037.09 (22.44)  045.30 (52.07) -0.85  0.403 
Triangular index  00.082 (0.083)  00.082 (0.063) -0.00  0.998 
Total power  0904.5 (927.8) 2427.2  (4500.3) -1.40  0.180 
LF power  0299.2 (286.5) 1594.5  (3248.9) -1.68  0.112 
HF power  0195.4 (201.6)  0752.1 (1273.8) -1.86  0.081 
LF/HF ratio  02.253 (1.737)  01.931 (3.509) 0.33  0.745 
Norm. LF power  047.96 (17.61)  039.20 (22.55) 1.68  0.112 
Hospital group 
Norm. HF power  029.97 (19.29)  050.21 (28.79) -2.24  0.040 
SDNN  00.047 (0.068)  00.038 (0.042) 0.61  0.547 
RMSSD  052.95 (90.67)  044.17 (64.75) 0.42  0.675 
Triangular index  00.058 (0.025)  00.053 (0.022) 0.50  0.621 
Total power  1762.4 (3627.5)  0615.7 (714.2) 1.33  0.203 
LF power  1132.4 (2502.8)  0256.8 (244.8) 1.41  0.177 
HF power  0513.5 (1066.4)  0335.2 (496.2) 0.78  0.447 
LF/HF ratio  03.486 (3.343)  02.020 (1.598) 1.63  0.122 
Norm. LF power  055.43 (30.00)  047.93 (26.86) 0.99  0.337 
Controls 
Norm. HF power  026.53 (19.67)  038.17 (22.78) -1.63  0.123 
Mean (SD), paired t-test. SDNN: standard deviation of NN interval, RMSSD: root of the mean squared differences of successive NN in-
tervals, LF: low frequency, HF: high frequency, Norm.: normalized    
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HF increased, and no positive result was found in the 
outpatient control group (Table 3). 
 
Salivary Cortisol Concentration 
Mean salivary cortisol concentration decreased from 
0.113 μg/dL to 0.082 μg/dL after the 4-week forest pro-
gram. The other programs did not show an effect, chang-
ing from 0.125 μg/dL to 0.132 μg/dL in the hospital 
group and from 0.137 μg/dL to 0.148 μg/dL in the out-
patient control group (Table 4). 
 
Routine health condition and health recognition 
scales 
Total scores of SF-36, measuring general health con-
ditions and wellness, did not show any group differences. 
In subcategories, subjective well-being and general ass-
essment of health was increased in the forest group but 
no difference was found in the other groups (Table 5). 
 
Discussion 
 
This study shows that the 4-week forest program im-
proved depressive symptoms and effectively induced re-
mission in patients taking medication for at least 3 months. 
Symptomatic improvement measured by mean HRSD 
score decreased from 15 to 8 in the forest group, which 
was better than the control group. Also, the remission rate, 
an important therapeutic goal defined by HRSD scores 
lower than 7, was higher in the forest group (14/23). This 
was a significant difference showing that CBT delivered 
in a forest environment is more effective than regular out-
patient treatment or CBT delivered in the hospital. Also, 
the 60% remission rate in our study, which included a 
combination of CBT and medication, was even better 
than clinical studies showing 30-40% of remission rate 
after 8 weeks of antidepressant medication.
13 
MADRS scores were even better. The forest program 
resulted in a reduction of more than 10 points, which was 
significantly better than the other groups. MADRS is more 
useful in evaluating psychological symptoms compared 
to HRSD, which focuses on physical conditions. The MA-
DRS scale is more frequently used to evaluate the effects 
of medical treatment because psychological changes are 
the core symptoms of depression, and although physical 
TABLE 4. Salivary cortisol concentrations before and after 4 week program in forest group, hospital group, and controls 
Salivary cortisol (μg/dL)  Before the 4 week program  After the 4 week program  t  p 
Forest group  0.113 (0.053) 0.082  (0.044)  -2.97 0.008 
Hospital group  0.125 (0.052) 0.132  (0.057) -1.62  0.121 
Controls 0.137  (0.100) 0.148  (0.106) -1.31  0.206 
Mean (SD), paired t-test 
 
TABLE 5. Short Form Health Survey Questionnaire (SF-36) scores before and after 4-week program in forest group, hospital group, and 
controls 
  Before the 4-week program After the 4-week program  t  p 
SF-36 total  66.20 (12.55) 69.73  (14.75) -1.56  0.134 
Functional status  81.75 (12.91) 80.37  (12.82) 0.51  0.611 
Well-being 58.15  (16.00) 63.85  (17.19) -2.17  0.043 
Overall estimation of health  55.67 (13.55) 63.33  (18.03) -3.25  0.004 
Physical health  72.30 (13.00) 74.32  (15.27) -0.94  0.356 
Forest group 
Mental health  59.79 (15.88) 64.43  (16.76) -1.73  0.099 
SF-36 total  60.85 (11.41) 57.85  (14.65) 1.15  0.269 
Functional status  69.62 (20.12) 71.85  (19.97) -0.72  0.481 
Well-being 54.05  (13.06) 50.25  (14.80) 0.97  0.345 
Overall estimation of health  59.77 (15.35) 59.11  (14.93) 0.65  0.683 
Physical health  66.40 (14.56) 62.97(19.26) 1.38  0.189 
Hospital group 
Mental health  54.57 (12.62) 52.76  (13.91) 0.50  0.623 
SF-36 total  54.46 (08.79) 54.53  (08.40) -0.07  0.944 
Functional status  68.33 (16.49) 70.27  (15.16) -0.93  0.362 
Well-being 45.76  (09.40) 45.30  (08.82) 0.42  0.676 
Overall estimation of health  48.33 (07.13) 46.16  (08.93) 1.27  0.217 
Physical health  60.00 (11.82) 60.41  (11.77) -0.27  0.785 
Controls 
Mental health  54.57 (12.62) 52.76  (13.91) 0.33  0.740 
Mean (SD), paired t-test 
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illnesses are also important, they usually respond chro-
nically. So an improved MARDS score means that the 
forest program has effectively improved the psycholo-
gical symptoms of depression.   
Parameters of HRV, including SDNN, RMSSD, RP and 
HF, were increased by the forest program. Time domain 
(SDNN and RMSSD) and frequency domain (TP) para-
meters indicates the total amount of HRV. A higher value 
means that the autonomic nervous system is well regu-
lated and generally low stress is loaded to the heart. The 
forest program increased parameters of HRV which is in-
terpreted to mean well regulated autonomic nervous sys-
tem tone. This was consistent with a study showing that 
the forest environment is helpful in increasing HRV
24 
and a study comparing HRV during mounting and tower 
climbing.
44 Parasympathetic tone was also increased ac-
cording to changes in HF score. The LF, LF/HF ratio, and 
index of sympathetic tone increased but without signi-
ficance. If the sympathetic tone increases while HRV 
decreases or does not change, it could be seen as a st-
ressful situation, but if the total amount of HRV incre-
ases, it is interpreted as a refreshing and useful stimu-
lation because parasympathetic tone has also increased. 
Meanwhile, the change of HRV in the hospital program 
was not significant but sympathetic tone increased ac-
cording to the normalized HF score. No changed was de-
tected in the outpatient control group. 
The forest program, but not the hospital or control pro-
gram, reduced salivary cortisol concentration, a bioche-
mical index of stress. Although it has wide diurnal and 
individual variation, it is widely accepted because find-
ing of a better alternative is difficult. A study on Japanese 
college students showed that activities in the forest de-
crease salivary cortisol concentrations more than activi-
ties in the city.
24 We assume salivary cortisol concentr-
ation decreased because the forest environment lessened 
the stress response of participants or improved depressive 
symptoms.
45 It is known that cortisol concentrations in-
crease in major depressive disorder. An interesting report 
showed that frequently relapsing patients have high cor-
tisol concentrations, even after symptoms improved with 
treatment.
46 The decrease of cortisol concentration may 
be a biological reflection of symptomatic improvement 
of depression. 
No group differences were found in the total SF-36 
score, measurement of general health status. In SF-36 
subscales, subjective wellness and general assessment of 
health improved in the forest group, but the improve-
ment in functional level was not significant. Subscale 
differences were not found in either the hospital or the 
control group. We presumed two reasons why functional 
level and SF-36 total score had not changed in the forest 
group: First, it would be difficult to make an objective 
interpretation about an individual’s own physical and 
psychological status in a self-assessment test, and in-
creased subjective well-being and general health status 
evaluation scores support this notion. Second, 4-week 
treatment adequate for obtaining symptomatic improve-
ment but may not be long enough to ensure functional 
improvement of depressive symptoms. 
In summary, 4 weeks of a forest activity program ef-
fectively improved depressive symptoms in patients tak-
ing antidepressant medication. The effect was superior 
to usual outpatient management. For MADRS score and 
remission rate, it was better than the program performed 
in hospital. Physiological indexes such as HRV and Sa-
livary cortisol also showed the superiority of the forest 
program to the hospital program and usual outpatient ma-
nagement.  
Recently the importance of remission has been em-
phasized because remission failure causes frequent relapse 
and poor prognosis, which disturb patients’ functional 
and social adaptations.
7,8 Pharmacotherapy alone does 
not seem to be good enough to reach the goal of complete 
recovery of social and occupational function. Patients 
tend to hardly escape from functional impairments be-
cause they feel afraid to return to their routine lives, and 
staying at home being lethargic has already became a 
habit even though depressive symptoms have improved. 
An optimized treatment method combining pharmacoth-
erapy and psychotherapy is required for a better outcome. 
This is the same reason why rehabilitation is continu-
ously needed after acute musculoskeletal disease, or why 
CBT to treat avoidance symptoms in post-traumatic stress 
disorder is required even after physical symptoms have 
improved through use of medications.   
To maximize the therapeutic effect, it is important to 
optimize the content and form of psychiatric management 
according to the disease characteristics. An environment 
like a hospital or forest in which psychotherapy is con-
ducted is not just a place, but in itself is a content and 
form of therapy that interacts with various other factors 
and possibly changes outcomes. We assume some rea-
sons why the forest is better than the hospital as an en-
vironmental element. Most importantly, patients can in-
teract with a multitude of integrated factors including 
sensory stimulations of vision, smell, sound, and touch 
coming from the forest and trees, fresh air and wide open 
space, comfortable temperature, and humidity. Even pa-
tients who do not like to move autonomously in build-
ings can become more active in the forest. Increasing 
activity is important for functional recovery in depressed 
patients, which has been shown in studies about the use-
fulness of walking in anxious or depressed patients
47 and  
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in opinions about the importance of behavioral activa-
tion in CBT.
48 For this reason, programs or workshops 
with practical approaches in an interactive environment 
may be better than simple advice or education telling pa-
tients to increase their activity levels. A forest environ-
ment can also facilitate interaction of psychological as 
well as physical activities. People can easily meditate or 
reconsider interpersonal problems while in the forest 
setting. In the hospital setting, patients often resist or 
avoid opening their minds, but the forest makes them 
speak out easily or connect with themselves through an 
object in nature. Therefore, interacting with the forest 
environment increases physical and psychological acti-
vities, which may have resulted in the therapeutic ef-
fects observed in this study.   
This study also had some limitations. It was hard to 
generalize our results because of the limited numbers of 
participants. Well-controlled, large scale trials are need-
ed to generalize the effects of the forest on human men-
tal health. The subjects were sequentially assigned to 3 
different groups, and were not fully randomized. But, 
these environmental interventions cannot be blind to the 
therapist and the subject. We also have the limitation that 
we did not assess patients’ motivations. Motivation is an 
important treatment factor for patients with depressive 
disorders, and may affect the decision of participation in 
this study and the treatment results. In the future, sup-
plemental research will be required. Studies comparing 
natural environments other than the forest will also be 
required.  
As far as we know, this was the first report in Korea 
studying forest environment as a therapeutic modality 
on patients with major depressive disorder applying me-
dical model on patients. It is widely accepted that the 
cost for the rehabilitation of chronically ill patients in-
cluding major depressive disorder is a huge problem. For 
complete remission from major depressive disorder, ph-
armacotherapy should be combined with psychothera-
peutic interventions, and use of adequate environmental 
elements like the forest may improve treatment outcome. 
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